Core Viewpoint - UnitedHealth Group (NYSE:UNH) is a leading healthcare company in the U.S., providing a wide range of health benefits and services, and competes with major players like Anthem and Cigna [1] Group 1: Stock Performance - On January 27, 2026, UNH's stock experienced a significant downturn, plummeting by 19.8% to $281.96, marking its worst single-day percentage loss since April [2] - The stock's decline amounted to $70.08, or approximately 19.93%, bringing its price to $281.56, with a trading day low of $280.40 and a high of $299.50 [3] - The trading volume for the day reached 56.14 million shares, indicating heightened investor activity amid the stock's sharp decline [4] Group 2: Market Outlook - Piper Sandler set a price target of $396 for UNH, suggesting a potential price increase of approximately 40.56% from its current trading price of $281.73 [2] - Despite the downturn, UNH's market capitalization remains robust at approximately $255.05 billion, highlighting its significant presence in the healthcare industry [5] - Over the past year, UNH has seen a high of $606.36 and a low of $234.60, showcasing its price fluctuations in the market [4]